Literature DB >> 17722970

Drug-induced cardiovascular disorders.

C Aengus Murphy1, Henry J Dargie.   

Abstract

As the variety and range of pharmaceutical agents available to the medical profession continues to expand, one unavoidable effect will be an increase in drug-induced disease, including cardiovascular disorders. However, given the high rates of cardiovascular disease and prevalence of recognised cardiovascular risk factors in the population, it is sometimes impossible to conclusively attribute any individual patients' ill health to one particular drug. As a result, the relationship between drugs and cardiovascular disease is often difficult to quantify. This review discusses specific forms of drug-induced cardiovascular disease such as heart failure, left ventricular systolic dysfunction, hypertension and arrhythmia. Suspected culprit drugs for all disorders are highlighted. Specific attention is given to certain drug groups with a strong association with one or more forms of cardiovascular disease: these include anthracyclines, antipsychotics, NSAIDs and cyclo-oxygenase 2 inhibitors. Additionally, advice is offered on how physicians might distinguish drug-induced cardiovascular disorders from other aetiologies.

Entities:  

Mesh:

Year:  2007        PMID: 17722970     DOI: 10.2165/00002018-200730090-00005

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  195 in total

1.  HIV-associated coronary arteritis in a patient with fatal myocardial infarction.

Authors:  G Barbaro; G Barbarini; A M Pellicelli
Journal:  N Engl J Med       Date:  2001-06-07       Impact factor: 91.245

2.  Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: a double-blind, placebo-controlled trial.

Authors:  T M Davis; L G Dembo; S A Kaye-Eddie; B J Hewitt; R G Hislop; K T Batty
Journal:  Br J Clin Pharmacol       Date:  1996-10       Impact factor: 4.335

Review 3.  Blood coagulation and oral contraceptives. A critical review.

Authors:  U H Winkler
Journal:  Contraception       Date:  1998-03       Impact factor: 3.375

4.  Serial electrocardiogram changes in acute tricyclic antidepressant overdoses.

Authors:  E L Liebelt; A Ulrich; P D Francis; A Woolf
Journal:  Crit Care Med       Date:  1997-10       Impact factor: 7.598

5.  Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?

Authors:  A Urhausen; T Albers; W Kindermann
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

6.  Suppression of plasma renin activity by cyclosporine.

Authors:  J P Bantle; R J Boudreau; T F Ferris
Journal:  Am J Med       Date:  1987-07       Impact factor: 4.965

7.  Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age.

Authors:  W H Inman; M P Vessey
Journal:  Br Med J       Date:  1968-04-27

8.  Diagnosis and treatment of acute poisoning with volatile substances.

Authors:  T J Meredith; M Ruprah; A Liddle; R J Flanagan
Journal:  Hum Toxicol       Date:  1989-07

9.  Cisapride-induced torsades de pointes.

Authors:  J Vitola; J Vukanovic; D M Roden
Journal:  J Cardiovasc Electrophysiol       Date:  1998-10

10.  Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.

Authors:  C A Haller; N L Benowitz
Journal:  N Engl J Med       Date:  2000-12-21       Impact factor: 176.079

View more
  6 in total

Review 1.  Diuretic use in renal disease.

Authors:  Domenic A Sica
Journal:  Nat Rev Nephrol       Date:  2011-12-20       Impact factor: 28.314

2.  The anti-protozoal drug pentamidine blocks KIR2.x-mediated inward rectifier current by entering the cytoplasmic pore region of the channel.

Authors:  T P de Boer; L Nalos; A Stary; B Kok; M J C Houtman; G Antoons; T A B van Veen; J D M Beekman; B L de Groot; T Opthof; M B Rook; M A Vos; M A G van der Heyden
Journal:  Br J Pharmacol       Date:  2010-02-24       Impact factor: 8.739

3.  Drugs and dilated cardiomyopathies: A case/noncase study in the French PharmacoVigilance Database.

Authors:  Guillaume Montastruc; Sylvie Favreliere; Agnès Sommet; Atul Pathak; Maryse Lapeyre-Mestre; Marie-Christine Perault-Pochat; Jean-Louis Montastruc
Journal:  Br J Clin Pharmacol       Date:  2010-03       Impact factor: 4.335

Review 4.  Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials.

Authors:  Lesley A Smith; Victoria R Cornelius; Christopher J Plummer; Gill Levitt; Mark Verrill; Peter Canney; Alison Jones
Journal:  BMC Cancer       Date:  2010-06-29       Impact factor: 4.430

5.  Characterization and Validation of a Human 3D Cardiac Microtissue for the Assessment of Changes in Cardiac Pathology.

Authors:  Caroline R Archer; Rebecca Sargeant; Jayati Basak; James Pilling; Jennifer R Barnes; Amy Pointon
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

6.  QTc interval prolongation in the patients with primary biliary cholangitis.

Authors:  Zihao Wang; Rongkai Qian; Yanhua Wang; Lingfei Mo; Bomiao Ju; Nan Hu; Pei Wang; Lan He; Jing Wang
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-12-02       Impact factor: 1.468

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.